Tweets
-
Buffett Buys $1.8 Billion ‘Gem’ of a Medical Insurer in New York https://t.co/nknIL8VuHA via @business -
a16z Podcast: Software Programs the World https://t.co/0LYBhIPGX7
-
This Cyborg Stingray Is the Coolest Thing You'll See All Day https://t.co/9pSO7xspJD?
-
Here are some ways cancer can thwart the new immunotherapy drugs https://t.co/0t1t3r8ZMQ
-
Unburdening the Facebook Generation by Mohamed A. El-Erian via @ProSyn https://t.co/1kMs1cJth9
-
Pensions stretched to breaking point after Brexit vote https://t.co/L5KFJCTKG5 via @FT
-
The NBA proves that unions work. The UFC shows why they're necessary. https://t.co/8igVkMXFz9 via @fusion
-
Where machines could replace humans--and where they can’t (yet) | McKinsey & Company https://t.co/kXFW6Aa1Xz
-
Hundreds of U.S. clinics selling unapproved stem cell "therapies" https://t.co/ZjfjaOsNlD
-
Why AI's massive disruptions may be just what you're looking for https://t.co/P4MeF3RMkz via @CNET
-
Stem Cell Clinics Selling Risky Treatments Explode Across the U.S. https://t.co/ri62unsAe8
-
Chinese Startup Wants to Predict Your Health With a Digital DNA Avatar https://t.co/2aYvuPrRxK via @technology
-
First CRISPR clinical trial gets green light from US panel https://t.co/qBSbsC8sjo
-
The Global Liquidity Trap Turns More Treacherous - Guggenheim Partners https://t.co/jxHkFHT3Rf
-
Forget December. Forget Next Year. The Fed's Done Hiking Until 2018 https://t.co/F4meWjZWWk
-
A Cautionary Tale of ‘Stem Cell Tourism’ https://t.co/eobzm4saRa
